Kaplan Quoted in Law360 Discussing the U.S. Department of Labor’s Emergency COVID-19 Safety Rule for Health Care Employers
June 18, 2021
Law360
Partner Daniel Kaplan was quoted in a Law360 article titled, “3 Things Employers Should Know as DOL Virus Rule Kicks In,” discussing the Occupational Safety and Health Administration’s Emergency Temporary Standard taking effect and how it will affect employers.
Kaplan told Law360, “That’s got to be implemented within 14 days, and I think many health care locations have seen a reduction in the restrictions on family members and others who visit loved ones in the hospital. And they’re now going to have to [ramp] that back up because they’re going to have to now do screening and triage pretty much at any entry point. That’s going to create, I think, some backlog and some confusion.”
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.